A Phase I Dose-Finding Study Using an Innovative Sequential Biweekly Schedule of Irinotecan Followed 24 Hours Later by Capecitabine

Author： Hirawat Samit   Kolitz Jonathan   Lichtman Stuart M.   Allen Steven L.   Villani Gina   Gonzales Alma   Fricano Marjorie   Budman Daniel R.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.25, Iss.3, 2007-04, pp. : 148-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors

By Saif Muhammad   Sellers Sandra   Li Mao   Wang Wei   Cusimano Linda   Wang Hui   Zhang Ruiwen  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 871-882

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

By Masuda Norikazu   Taguchi Tetsuya   Nakayama Takahiro   Shiba Eiichi   Watatani Masahiro   Kurebayashi Junichi   Takatsuka Yuichi   Sakamoto Junichi   Noguchi Shinzaburo  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 989-995

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

By Trocòniz Iñaki   Garrido María   Segura Cristina   Cendrós Josep-María   Principe Paola   Peraire Concepción   Obach Rosendo  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 727-735

Springer Publishing Company

Access to resources Recommend Favorite

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

By Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer

By Souglakos J.   Androulakis N.   Mavroudis D.   Kourousis C.   Kakolyris S.   Vardakis N.   Kalbakis K.   Pallis A.   Ardavanis A.   Varveris C.   Georgoulias V.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 56, Iss. 5, 2003-08 ,pp. : 1284-1287

Elsevier

Access to resources Recommend Favorite